We don’t comment primarily on health applications of telecommunications technologies, or on public health initiatives. We’re firstly about health care that features convenience (I like convenience. People like convenience).
We remind you, dear reader, of our principal theme to give you context for our posting the following links to two otherwise apparently unrelated health care topics, both identified by their authors or editors as about “mobile health”:
Mobile Clinics Seen As A Way To Cut US Health Bill (Scott Malone, Reuters, 8/11/10; immediate access)
The [Family Van] — which visits six low-income neighborhoods around Boston weekly — is one of about 2,000 such mobile clinics in the United States. Advocates say the approach can help control the rising cost of health care by helping people with chronic diseases to stay out of the emergency room, often the first recourse for inner-city residents.
Mobile Health and the FDA: What WellDoc’s Approval Means for mHealth (Jane Sarasohn-Kahn, HealthPopuli, 8/10/10; immediate access)
While an “N” of 1 = 1, and WellDoc’s approval is for one product from one company, the approval of DiabetesManager represents a positive sign for the many developers of mobile health applications waiting in the wings for market approval.
We’re confident that your familiarity with Healthcare 311 would equip you to advise those authors & editors that their subjects are also squarely in the realm of “convenient health”.
Because they are.


25
Aug 10
Take Care Health Congratulates Itself For Engaging Its Clientele
On the other hand, what else are press releases for, anyway?
Exceptional Patient Experience Delivered at Take Care Clinics at Select Walgreens
Before we continue – who knew you could grow up to be a customer engagement scientist? Sounds cool.
We understand Take Care Health’s and Gallup’s enthusiasm for the kind of customer engagement Take Care clinics are generating. What we don’t understand is this: given retail clinics’ focus on episodic care, and their explicit public commitment to supporting customers’ development and/or maintenance of relationships with primary care physicians, shouldn’t ‘scoring’ engagement success based on actual customer return visits be viewed as ambiguous at best? (We can set aside that, as a practical matter, Take Care will have a tough job gathering objective evidence that customers have in fact followed through on care recommendations from their Take Care visits).